Scientific Advisory Board (SAB)

CANCER-ID is supported by a Scientific Advisory Board. This board shall ensure the highest standard of research and monitor the progress of the project by taking part in the annual meetings. Whenever appropriate, they will consult the consortium and make recommendations on how to best improve project performance.

The CANCER-ID SAB consists of nine experts representing the key areas of the project.

Prof. Anastassia Negrouk, European Organisation for Research and Treatment of Cancer
Prof. Charles Swanton, London Research Institute
Prof. Dave SB Hoon, John Wayne Cancer Institute, Saint John´s Health Center
Prof. George A. Calin, MD Anderson Cancer Center
Prof. Maarten J. IJzerman, University of Twente
Ursula Goldmann-Posch, mamazone
Prof. Stefanie Jeffrey, Stanford Medicine
Prof. Yibin Kang, Princeton University
Prof. Michael Thomas, University of Heidelberg